- About Us
- Advertise
- Editorial Information
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Jim Miller
Articles
CDMOs Driving Emerging Bio/Pharma Success
CDMOs can claim credit for the robust growth of emerging bio/pharma financings.
What to Watch for in 2018
The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.
CDMO Acquisitions Build Strategic Supplier Base
Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.
Up and Away, M&A
Mergers and acquisitions are positive for the CDMO industry, but there is a downside.